| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |